Cargando…
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome
OBJECTIVES: The outbreak of COVID-19 posed the issue of urgently identifying treatment strategies. Colchicine was considered for this purpose based on well-recognised anti-inflammatory effects and potential antiviral properties. In the present study, colchicine was proposed to patients with COVID-19...
Autores principales: | Scarsi, Mirko, Piantoni, Silvia, Colombo, Enrico, Airó, Paolo, Richini, Donata, Miclini, Marco, Bertasi, Valeria, Bianchi, Marta, Bottone, Damiano, Civelli, Patrizia, Cotelli, Maria-Sofia, Damiolini, Ezio, Galbassini, Gloria, Gatta, Diego, Ghirardelli, Maria-Laura, Magri, Roberto, Malamani, Paola, Mendeni, Monia, Molinari, Stefano, Morotti, Andrea, Salada, Luisa, Turla, Marinella, Vender, Angiola, Tincani, Angela, Brucato, Antonio, Franceschini, Franco, Furloni, Roberto, Andreoli, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509521/ https://www.ncbi.nlm.nih.gov/pubmed/32732245 http://dx.doi.org/10.1136/annrheumdis-2020-217712 |
Ejemplares similares
-
The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al.
por: Piantoni, Silvia, et al.
Publicado: (2020) -
Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of Therapy
por: Piantoni, Silvia, et al.
Publicado: (2021) -
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab
por: Regola, Francesca, et al.
Publicado: (2019) -
Clinical and neurophysiological characteristics of heterozygous NPC1 carriers
por: Benussi, Alberto, et al.
Publicado: (2019) -
Reduced T-cell repertoire restrictions in abatacept-treated rheumatoid arthritis patients
por: Imberti, Luisa, et al.
Publicado: (2015)